Chemistry, part 1

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > ureas > n-[(1r)-1-[(/{[(5s)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl/}sulfonyl)methyl]-2-oxo-2-(/{(1s)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl/}amino)ethyl]morpholine-4-carboxamide

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > n-[(1r)-1-[(/{[(5s)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl/}sulfonyl)methyl]-2-oxo-2-(/{(1s)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl/}amino)ethyl]morpholine-4-carboxamide

organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > n-[(1r)-1-[(/{[(5s)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl/}sulfonyl)methyl]-2-oxo-2-(/{(1s)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl/}amino)ethyl]morpholine-4-carboxamide

organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > n-[(1r)-1-[(/{[(5s)-3,5-dimethyl-2,5-dihydroisoxazol-4-yl]methyl/}sulfonyl)methyl]-2-oxo-2-(/{(1s)-3-phenyl-1-[2-(phenylsulfonyl)ethyl]propyl/}amino)ethyl]morpholine-4-carboxamide